Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal composition for treating rhinitis and application thereof

A composition and drug technology, applied in the direction of drug combination, drug delivery, medical preparations containing active ingredients, etc., can solve problems such as toxic side effects, inability to complete treatment, and achieve precise compatibility, good patient compliance, and good therapeutic effects. Effect

Active Publication Date: 2015-01-07
CHENGDU COMFAITH PHARMA
View PDF2 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, these drugs have certain toxic and side effects on the human body, and they still cannot be completely cured

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition for treating rhinitis and application thereof
  • Medicinal composition for treating rhinitis and application thereof
  • Medicinal composition for treating rhinitis and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] The preparation of embodiment 1 composition of the present invention

[0031] Magnolia flower essential oil: 10g, Goose Bubivorous essential oil: 5g, Peppermint essential oil: 2g, Huoxiang essential oil: 5g, Wild chrysanthemum essential oil: 5g, Guizhi essential oil: 1g. After the essential oils are mixed evenly, the composition of the present invention is obtained. After being absorbed by activated carbon carrier, it is placed in the nasal cavity applicator.

[0032] The beneficial effects of the present invention will be specifically described below through test examples.

[0033] In the test example of the present invention, the nasal cavity applicators used are nose clips, and each nose clip is equipped with 2 pieces with an average volume of about 0.3cm 3 Activated carbon particles, activated carbon particles adsorb essential oils to saturation.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a medicinal composition for treating rhinitis. The medicinal composition is prepared from the following raw materials in parts by weight: 5-15 parts of magnolia flower essential oil, 2-8 parts of centipeda minima essential oil, 1-5 parts of mint essential oil, 2-8 parts of agastache rugosa essential oil, 2-8 parts of wild chrysanthemum essential oil, and 1-5 parts of cassia twig essential oil. The invention further provides a preparation method and application of the composition. The study results show that the medicinal composition has a good therapeutic effect on chronic rhinitis and allergic rhinitis, is precise and appropriate in compatibility, and obviously superior to the medicinal composition with a different formula in pharmacological activity; meanwhile, the medicinal composition is not required to be orally taken or injected, so that the patient compliance is better and a novel choice is provided for clinical medication.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating rhinitis. Background technique [0002] Rhinitis is an inflammatory disease of the nasal cavity, which is the inflammation of the nasal mucosa caused by viruses, bacteria, allergens, various physical and chemical factors, and certain systemic diseases. Chronic allergic rhinitis is allergic rhinitis, which refers to the release of mediators (mainly histamine) mediated by IgE after exposure to allergens in atopic individuals, and a variety of immune active cells and cytokines are involved. Noninfectious inflammatory disease of the mucosa. There are three necessary conditions for its occurrence: ① Specific antigen is the substance that causes the body's immune response. ② Atopic individuals are the so-called individual differences and allergies. ③ The specific antigen meets the atopic individual. Allergic rhinitis is a global health problem that causes many diseases and lost labor. Th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/575A61K9/72A61P11/02
CPCA61K9/0043A61K36/28A61K36/287A61K36/532A61K36/534A61K36/54A61K36/575A61K2300/00
Inventor 夏隆江何宇新刘蓓李昌龙张翠媚
Owner CHENGDU COMFAITH PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com